Huntington Disease

2 protocols meet the specified criteria

OCR16456

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

OCR18614

A Phase 2, multi-center, randomized, double-blind, placebo controlled study in subjects with late prodromal and early manifest Huntington's disease (HD) to assess the safety, tolerability, pharmacokinetics, and efficacy of VX15/2503